FOLFIRINOX + NIS793 in Pancreatic Cancer

NCT05417386 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped NIS793 is no longer being developed

Conditions

Pancreas Cancer
Metastatic Pancreatic Cancer
Metastatic Pancreatic Adenocarcinoma

Interventions

DRUG: FOLFIRINOX
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: Irinotecan
DRUG: 5-Fluorouracil (5-FU)
DRUG: NIS793
RADIATION: Chemoradiation
DRUG: Capecitabine
RADIATION: Radiation Therapy
PROCEDURE: Surgery

Sponsor

Colin D. Weekes, M.D., PhD

Collaborators

[object Object]